References
- Fraser GE, Franke AA, Jaceldo-Siegl K, Bennett H. (2010). Reliability of serum and urinary isoflavone estimates. Biomarkers 15:135–9
- Fritz H, Seely D, Flower G, et al. (2013). Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One 8:e81968
- Grace PB, Taylor JI, Botting NP, et al. (2003). Quantification of isoflavones and lignans in urine using gas chromatography/mass spectrometry. Anal Biochem 315:114–20
- Hauser R, Meeker JD, Park S, et al. (2004). Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect 112:1734–40
- Hwang YW, Kim SY, Jee SH, et al. (2009). Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer 61:598–606
- Jefferson WD, Patisaul HB, Williams CJ. (2012). Reproductive consequences of developmental phytoestrogen exposure. Reproduction 143:247–60
- Kile ML, Hoffman E, Hsueh YM, et al. (2009). Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117:455–60
- Lee S-A, Wen W, Xing Y-B, et al. (2007). Assessment of dietary isoflavone intake among middle-aged Chinese men. J Nutr 137:1011–16
- Liu W, Tanabe M, Harada KH, Koizumi A. (2013). Levels of urinary isoflavones and lignin polyphenols in Japanese women. Environ Health Prev Med 18:394–400
- Meeker JD, Cantonwine DE, Rivera-González LO, et al. (2013). Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol 47:3439–47
- Niwa M, Suzuki Y, Yoshinaga J, et al. (2011). Prenatal exposure to polycyclic aromatic hydrocarbons and birth outcomes. Polycyclic Aromat Comp 31:16–27
- Pérez-Jiménez J, Hubert J, Hooper L, et al. (2010). Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. Am J Clin Nutr 92:801–9
- Reinwald S, Weaver CM. (2006). Soy isoflavones and bone health: a double-edged sword? J Nat Prod 69:450–9
- Rivera-Núñez Z, Meliker JR, Linder AM, Nriagu JO. (2010). Reliability of spot urine samples in assessing arsenic exposure. Int J Hyg Environ Health 213:259–64
- Rosner B. (2006). Fundamentals of biostatistics. 6th ed. Belmont (CA): Thomson-Brooks/Cole
- Setchell KDR, Faughnan MS, Avades T, et al. (2003). Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77:411–19
- Shirai S, Suzuki Y, Yoshinaga J, et al. (2013). Urinary excretion of parabens in pregnant Japanese women. Reprod Toxicol 35:96–101
- Suzuki Y, Niwa M, Yoshinaga J, et al. (2009). Exposure assessment of phthalate esters in Japanese pregnant women by using urinary metabolite analysis. Environ Health Prev Med 14:180–7
- Suzuki Y, Yoshinaga J, Mizumoto Y, et al. (2012). Foetal exposure to phthalate esters and anogenital distance in male newborns. Int J Androl 35:236–44
- Teitelbaum SL, Britton JA, Calafat AM, et al. (2008). Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res 106:257–69
- Tham DM, Gardner CD, Haskell WL. (1998). Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrin Metab 83:2223–35